Global cancer immunotherapy sales share by type 2014 and 2021 forecast
Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by type
This statistic depicts the global cancer immunotherapy sales distribution in 2014 and a projection for 2021, by type. Therapeutic vaccines made up some 15 percent of global cancer immunotherapy sales in 2014. This share is expected to decrease to around four percent by 2021.
Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by type
Source
More information
Statistics on "Cancer"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Number of cancer immunotherapy companies by country of origin 2015
- New targeted cancer immunotherapies available in selected countries 2015
- Distribution of cancer immunotherapies by technology 2015
- Oncology treatment modality changes worldwide 2003 and 2013
- Share of oncology biologics and non-biologic market 2003-2013
- Distribution of active oncology products along the drug pipeline February 2014
- Number of active oncology products along the pipeline in BRIC countries 2014
- Oncology spending in selected developed countries 2015
- Number of oncology NMEs launched by biologics and non-biologic 2004-2013
- Global market forecast of oncologics and supportive care biosimilars 2020
- Net price index for cancer products in developed markets 2014
- Oncology spending as share of pharmaceutical spending by country 2015
- Oncology spending worldwide by region 2015 vs. 2020
- U.S. average invoice price increase for oncology brands 2012-2017
- Share of Canadians leaving the country for radiation oncology in 2016, by province
- Usage of electronic health records at oncology practices in the U.S. 2012-2013
- Oncology therapeutic spending growth 2013-2018 U.S. vs pharmerging
- Number of oncology practices in the U.S. by region and size 2013
Statistics on "Cancer"
Related topics
About Statista
